1505
A pharmacokinetic interaction between the selective serotonin reuptake inhibitor citalopram and a tricyclic antidepressant, clomipramine, was noted in a patient treated for major depression and obsessive-compulsive disorder.
 a patient treated for major depression and obsessive-compulsive disorder: Subject; A pharmacokinetic interaction: Effect; the selective serotonin reuptake inhibitor citalopram and a tricyclic antidepressant, clomipramine: Treatment; citalopram: Treatment.Drug; clomipramine: Treatment.Drug; depression: Treatment.Disorder; obsessive-compulsive disorder: Treatment.Disorder; citalopram: Combination.Drug; clomipramine: Combination.Drug
Given event type and trigger, please tell me the arguments of all the listed option. Output format is "name1: role1; name2: role2". 
Event type: adverse event 
  Option: Treatment.Freq, Subject.Population, Combination.Drug, Subject.Gender, Treatment.Duration, Subject, Effect, Treatment, Treatment.Disorder, Subject.Disorder, Treatment.Route, Subject.Race, Treatment.Time_elapsed, Treatment.Dosage, Subject.Age, Treatment.Drug 
Text: {0} 
Answer:
 a patient treated for major depression and obsessive-compulsive disorder: Subject; A pharmacokinetic interaction: Effect; the selective serotonin reuptake inhibitor citalopram and a tricyclic antidepressant, clomipramine: Treatment; citalopram: Treatment.Drug; clomipramine: Treatment.Drug; depression: Treatment.Disorder; obsessive-compulsive disorder: Treatment.Disorder; citalopram: Combination.Drug; clomipramine: Combination.Drug